✦ LIBER ✦

Losartan reduces the costs of diabetic end-stage renal disease: An Asian perspective

✍ Scribed by WONG KOK SENG; SHANG-JYH HWANG; DONG CHEOL HAN; CHUA CHIN TEONG; JULIANA CHAN; THOMAS A BURKE; GEORGE W CARIDES; YON JONG CHOI

Book ID: 108959013
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 70 KB
Volume: 10
Category: Article
ISSN: 1320-5358
DOI: 10.1111/j.1440-1797.2005.00472.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal disease in relatives of Indo-Asian

Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy

✍ P. K. Chandie Shaw; L. A. van Es; L. C. Paul; F. R. Rosendaal; J. H. M. Souverij 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 107 KB

Losartan and the United States costs of

Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy

✍ Alexander, Charles M.; Lyle, Paulette A.; Keane, William F.; Carides, George W.; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

Chronic kidney disease care program impr

Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs

✍ SHU-YI WEI; YONG-YUAN CHANG; LIH-WEN MAU; MING-YEN LIN; HERNG-CHIA CHIU; JER-CHI 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

The conundrum of increased burden of end

The conundrum of increased burden of end-stage renal disease in Asians

✍ HALL, YOSHIO N; HSU, CHI-YUAN; IRIBARREN, CARLOS; DARBINIAN, JEANNE; MCCULLOCH, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Remission of nephrotic-range albuminuria

Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients

✍ K. Rossing; P. K. Christensen; P. Hovind; H.-H. Parving 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 116 KB

Illustrating the impact of including fut

Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care

✍ Braden Manns; David Meltzer; Ken Taub; Cam Donaldson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract There are strong theoretical arguments for including future costs for related and unrelated medical care and non‐medical expenditures within economic evaluations. Nevertheless, there is limited data on how inclusion of such costs affects the cost effectiveness of medical interventions i